Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 1
Status:
Recruiting
Trial end date:
2024-08-31
Target enrollment:
Participant gender:
Summary
This study seeks to determine the feasibility, acceptability, and preliminary efficacy of an
intervention consisting of off-label use of a medication with strong efficacy data for
alcohol use disorder (AUD) with medical management and a clinical pharmacist-delivered
behavioral intervention in reducing alcohol use among individuals with HIV and AUD.
Phase:
N/A
Details
Lead Sponsor:
Yale University
Collaborator:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)